BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37461056)

  • 1. Genomic alterations related to HPV infection status in a cohort of Chinese prostate cancer patients.
    Lang B; Cao C; Zhao X; Wang Y; Cao Y; Zhou X; Zhao T; Wang Y; Liu T; Liang W; Hu Z; Tian X; Zhang J; Yan Y
    Eur J Med Res; 2023 Jul; 28(1):239. PubMed ID: 37461056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
    Seiwert TY; Zuo Z; Keck MK; Khattri A; Pedamallu CS; Stricker T; Brown C; Pugh TJ; Stojanov P; Cho J; Lawrence MS; Getz G; Brägelmann J; DeBoer R; Weichselbaum RR; Langerman A; Portugal L; Blair E; Stenson K; Lingen MW; Cohen EE; Vokes EE; White KP; Hammerman PS
    Clin Cancer Res; 2015 Feb; 21(3):632-41. PubMed ID: 25056374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Progression of High Grade Prostatic Intraepithelial Neoplasia to Prostate Cancer.
    Jung SH; Shin S; Kim MS; Baek IP; Lee JY; Lee SH; Kim TM; Lee SH; Chung YJ
    Eur Urol; 2016 May; 69(5):823-30. PubMed ID: 26542946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Landscape of Primary and Recurrent Anal Squamous Cell Carcinomas in Relation to HPV Integration, Copy-Number Variation, and DNA Damage Response Genes.
    Aldersley J; Lorenz DR; Mouw KW; D'Andrea AD; Gabuzda D
    Mol Cancer Res; 2021 Aug; 19(8):1308-1321. PubMed ID: 33883185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of evidence of HPV etiology of prostate cancer following radical surgery and higher frequency of the Arg/Pro genotype in Turkish men with prostate cancer.
    Aydin M; Bozkurt A; Cikman A; Gulhan B; Karabakan M; Gokce A; Alper M; Kara M
    Int Braz J Urol; 2017; 43(1):36-46. PubMed ID: 28124524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic Profiling of Prostate Cancers from Men with African and European Ancestry.
    Koga Y; Song H; Chalmers ZR; Newberg J; Kim E; Carrot-Zhang J; Piou D; Polak P; Abdulkadir SA; Ziv E; Meyerson M; Frampton GM; Campbell JD; Huang FW
    Clin Cancer Res; 2020 Sep; 26(17):4651-4660. PubMed ID: 32651179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Genomics of Prostate Cancer: emerging understanding with technologic advances.
    Rubin MA; Demichelis F
    Mod Pathol; 2018 Jan; 31(S1):S1-11. PubMed ID: 29297493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of disease-causing mutations in prostate cancer by NGS sequencing.
    Mangolini A; Rocca C; Bassi C; Ippolito C; Negrini M; Dell'Atti L; Lanza G; Gafà R; Bianchi N; Pinton P; Aguiari G
    Cell Biol Int; 2022 Jul; 46(7):1047-1061. PubMed ID: 35347810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies.
    Cyrta J; Prandi D; Arora A; Hovelson DH; Sboner A; Rodriguez A; Fedrizzi T; Beltran H; Robinson DR; Gopalan A; True L; Nelson PS; Robinson BD; Mosquera JM; Tomlins SA; Shen R; Demichelis F; Rubin MA
    J Pathol; 2022 Jul; 257(3):274-284. PubMed ID: 35220606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53 alterations of hormone-naïve prostate cancer in the Chinese population.
    Liu Z; Guo H; Zhu Y; Xia Y; Cui J; Shi K; Fan Y; Shi B; Chen S
    Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):482-491. PubMed ID: 33214693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus and the landscape of secondary genetic alterations in oral cancers.
    Gillison ML; Akagi K; Xiao W; Jiang B; Pickard RKL; Li J; Swanson BJ; Agrawal AD; Zucker M; Stache-Crain B; Emde AK; Geiger HM; Robine N; Coombes KR; Symer DE
    Genome Res; 2019 Jan; 29(1):1-17. PubMed ID: 30563911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic heterogeneity and copy number variant burden are associated with poor recurrence-free survival and 11q loss in human papillomavirus-positive squamous cell carcinoma of the oropharynx.
    Schrank TP; Lenze N; Landess LP; Hoyle A; Parker J; Lal A; Sheth S; Chera BS; Patel SN; Hackman TG; Major MB; Issaeva N; Yarbrough WG
    Cancer; 2021 Aug; 127(15):2788-2800. PubMed ID: 33819343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic Alterations in Human Papillomavirus-Positive and -Negative Conjunctival Squamous Cell Carcinomas.
    Ramberg I; Vieira FG; Toft PB; von Buchwald C; Funding M; Nielsen FC; Heegaard S
    Invest Ophthalmol Vis Sci; 2021 Nov; 62(14):11. PubMed ID: 34779821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in prostate cancer research: large-scale genomic analyses reveal novel driver mutations and DNA repair defects.
    Frank S; Nelson P; Vasioukhin V
    F1000Res; 2018; 7():. PubMed ID: 30135717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular evaluation of human papillomavirus as an oncogenic biomarker in prostate cancer.
    Sosse SA; Laraqui A; Mrabti M; Alami M; Mzibri ME; Ennaji MM
    Mol Biol Rep; 2023 Jul; 50(7):5719-5724. PubMed ID: 37217619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic alterations caused by HPV integration in a cohort of Chinese endocervical adenocarcinomas.
    Li W; Lei W; Chao X; Song X; Bi Y; Wu H; Wu M; Li L
    Cancer Gene Ther; 2021 Dec; 28(12):1353-1364. PubMed ID: 33398034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.
    Mandal RK; Gangwar R; Mandhani A; Mittal RD
    DNA Cell Biol; 2010 Apr; 29(4):183-90. PubMed ID: 20070155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The assessment of a possible link between HPV-mediated inflammation, apoptosis, and angiogenesis in Prostate cancer.
    Sadri Nahand J; Esghaei M; Hamidreza Monavari S; Moghoofei M; Jalal Kiani S; Mostafaei S; Mirzaei H; Bokharaei-Salim F
    Int Immunopharmacol; 2020 Nov; 88():106913. PubMed ID: 32889239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
    Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papilloma virus (HPV) and prostate cancer (PCa): The potential role of HPV gene expression and selected cellular MiRNAs in PCa development.
    Khatami A; Nahand JS; Kiani SJ; Khoshmirsafa M; Moghoofei M; Khanaliha K; Tavakoli A; Emtiazi N; Bokharaei-Salim F
    Microb Pathog; 2022 May; 166():105503. PubMed ID: 35398468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.